Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2429 (LINC02429) is a human gene that produces a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs (lncRNAs) defined as autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap protein-coding genes[1][3][5]. LincRNAs, including LINC02429, are typically involved in the regulation of gene expression at transcriptional and epigenetic levels, often modulating chromatin structure, recruiting regulatory proteins, or acting as enhancer RNAs[5]. While the biological functions of many lincRNAs remain under-characterized, they are generally viewed as fine-tuners of gene expression, and some have been shown to influence processes such as chromatin remodeling, transcription regulation, and possibly cell-type-specific regulatory activity[5]. As of now, there is no evidence that LINC02429 itself is a therapeutic target or that it interacts with any drugs, nor is there direct evidence linking it to specific diseases[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2429 (LINC02429).